Breast Cancer, Version 3.2020

被引：627

作者：

Gradishar, William J. ^{[1
]}

Anderson, Benjamin O. ^{[2
]}

Abraham, Jame ^{[3
,4
]}

Aft, Rebecca ^{[5
,6
]}

Agnese, Doreen ^{[7
,8
]}

Allison, Kimberly H. ^{[9
]}

Blair, Sarah L. ^{[10
]}

Burstein, Harold J. ^{[11
]}

Dang, Chau ^{[12
]}

Elias, Anthony D. ^{[13
]}

Giordano, Sharon H. ^{[14
]}

Goetz, Matthew P. ^{[15
]}

Goldstein, Lori J. ^{[16
]}

Isakoff, Steven J. ^{[17
]}

Krishnamurthy, Jairam ^{[18
]}

Lyons, Janice ^{[3
,4
]}

Marcom, P. Kelly ^{[19
]}

Matro, Jennifer ^{[20
]}

Mayer, Ingrid A. ^{[21
]}

Moran, Meena S. ^{[22
]}

Mortimer, Joanne ^{[23
]}

O'Regan, Ruth M. ^{[24
]}

Patel, Sameer A. ^{[16
]}

Pierce, Lori J. ^{[25
]}

Rugo, Hope S. ^{[26
]}

Sitapati, Amy ^{[10
]}

Smith, Karen Lisa ^{[27
]}

Smith, Mary Lou ^{[28
]}

Soliman, Hatem ^{[29
]}

Stringer-Reasor, Erica M. ^{[30
]}

Telli, Melinda L. ^{[9
]}

Ward, John H. ^{[31
]}

Young, Jessica S. ^{[32
]}

Burns, Jennifer L. ^{[33
]}

Kumar, Rashmi ^{[33
]}

机构：

[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[2] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[3] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[5] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[6] Washington Univ, Sch Med, St Louis, MO USA

[7] Ohio State Univ, Comprehens Canc Ctr, James Canc Hosp, Columbus, OH 43210 USA

[8] Solove Res Inst, Columbus, OH USA

[9] Stanford Canc Inst, Stanford, CA USA

[10] UC San Diego Moores Canc Ctr, La Jolla, CA USA

[11] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[12] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[13] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[15] Mayo Clin, Canc Ctr, Rochester, MN USA

[16] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[17] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[18] Fred & Pamela Buffet Canc Ctr, Omaha, NE USA

[19] Duke Canc Inst, Durham, NC USA

[20] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[21] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[22] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[23] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[24] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[25] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[26] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[27] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[28] Res Advocacy Network, Plano, TX USA

[29] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[30] UAB, ONeal Comprehens Canc Ctr, Barcelona, Spain

[31] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[32] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[33] Natl Comprehens Canc Network, Plymouth Meeting, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2020年 / 18卷 / 04期

关键词：

PHASE-III TRIAL; FULVESTRANT; 500; MG; FIRST-LINE THERAPY; ANASTROZOLE; LAPATINIB PLUS CAPECITABINE; AROMATASE INHIBITOR THERAPY; PROGRESSION-FREE SURVIVAL; ALBUMIN-BOUND PACLITAXEL; SCALP COOLING DEVICE; EPOTHILONE-B ANALOG;

D O I：

10.6004/jnccn.2020.0016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Several new systemic therapy options have become available for patients with metastatic breast cancer, which have led to improvements in survival. In addition to patient and clinical factors, the treatment selection primarily depends on the tumor biology (hormone-receptor status and HER2-status). The NCCN Guidelines specific to the workup and treatment of patients with recurrent/stage IV breast cancer are discussed in this article.

引用

页码：452 / 478

页数：27

共 181 条

[1] Dose-response trial of megestrol acetate in advanced breast cancer: Cancer and leukemia group B phase III study 8741
Abrams, J
Aisner, J
Cirrincione, C
Berry, DA
Muss, HB
Cooper, MR
Henderson, IC
Panasci, L
Kirshner, J
Ellerton, J
Norton, L
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 64 - 73
[2] Adams S, 2019, ANN ONCOL, V30, P405, DOI [10.1093/annonc/mdy518, 10.1093/annonc/mdy517]
[3] Gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment
Albain, Kathy S.
Nag, Shona M.
Calderillo-Ruiz, German
Jordaan, Johann P.
Llombart, Antonio C.
Pluzanska, Anna
Rolski, Janusz
Melemed, Allen S.
Reyes-Vidal, Jose M.
Sekhon, Jagdev S.
Simms, Lorinda
O'Shaughnessy, Joyce
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) : 3950 - 3957
[4] Albain KS, 2004, P ASCO, V22, P510, DOI DOI 10.1200/JC0.2004.22.14_
[5] Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial
Amadori, Dino
Aglietta, Massimo
Alessi, Barbara
Gianni, Lorenzo
Ibrahim, Toni
Farina, Gabriella
Gaion, Fernando
Bertoldo, Francesco
Santini, Daniele
Rondena, Roberta
Bogani, Paola
Ripamonti, Carla I.
[J]. LANCET ONCOLOGY, 2013, 14 (07) : 663 - 670
[6] ANDERSSON M, 1986, CANCER TREAT REP, V70, P1181
[7] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
Andre, Fabrice
Ciruelos, Eva
Rubovszky, Gabor
Campone, Mario
Loibl, Sibylle
Rugo, Hope S.
Iwata, Hiroji
Conte, Pierfranco
Mayer, Ingrid A.
Kaufman, Bella
Yamashita, Toshinari
Lu, Yen-Shen
Inoue, Kenichi
Takahashi, Masato
Papai, Zsuzsanna
Longin, Anne-Sophie
Mills, David
Wilke, Celine
Hirawat, Samit
Juric, Dejan
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) : 1929 - 1940
[8] [Anonymous], CANC RES S
[9] [Anonymous], 2019, J CLIN ONCOL S
[10] [Anonymous], 2019, J CLIN ONCOL S

← 1 2 3 4 5 6 7 8 9 10 →